Abirami Sharma

P1.085. Real-World Outcomes of Double Checkpoint Inhibition for MSI-H Gastroesophageal Adenocarcinoma

Abstract Topic Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Background Gastroesophageal Adenocarcinoma (GEA) is a leading cause of cancer worldwide, with up to 10% of cases harbouring microsatellite instability (MSI-H) characterized by mutations in mismatch-repair prote...